Loading…

The cost‐effectiveness of testing for NS 5a resistance‐associated polymorphisms at baseline in genotype 1a‐infected (treatment‐naïve and treatment‐experienced) subjects treated with all‐oral elbasvir/grazoprevir regimens in the United States

Saved in:

Bibliographic Details
Published in:	Alimentary pharmacology & therapeutics 2017-02, Vol.45 (3), p.455-467
Main Authors:	Elbasha, E. H., Robertson, M. N., Nwankwo, C.
Format:	Article
Language:	English
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!